{
"id":"mk19_bb_on_s4",
"subspecialtyId":"on",
"title":"Colorectal Cancer",
"jsonContent":{
"type":"section",
"id":"mk19_bb_on_s4",
"title":{
"__html":"Colorectal Cancer"
},
"titleNode":{
"type":"section-title",
"hlId":"45297c",
"children":[
"Colorectal Cancer"
]
},
"children":[
{
"type":"section",
"id":"mk19_bb_on_s4_1",
"title":{
"__html":"Screening"
},
"titleNode":{
"type":"section-title",
"hlId":"db7551",
"children":[
"Screening"
]
},
"children":[
{
"type":"p",
"hlId":"43fbed",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Average risk:"
]
},
" See General Internal Medicine chapter for ",
{
"type":"abbreviation",
"title":"U.S. Preventive Services Task Force",
"children":[
"USPSTF"
]
},
"-recommended screening."
]
},
{
"type":"p",
"hlId":"231f10",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"High risk:"
]
},
" The risk for colorectal cancer is elevated in inflammatory bowel disease; patients with pancolitis are at highest risk, whereas risk is negligible in patients with proctitis. Risk is also increased with longer duration of disease and coexistent ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"primary sclerosing cholangitis",
"children":[
"PSC"
]
},
"."
]
}
]
},
{
"type":"p",
"hlId":"d21d92",
"children":[
" ",
{
"type":"alert",
"children":[
"The following is a list of the most common hereditary syndromes:"
]
},
" "
]
},
{
"type":"p",
"hlId":"9826c3",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Familial adenomatous polyposis"
]
},
" is an autosomal dominant disorder that requires prophylactic colectomy."
]
},
{
"type":"p",
"hlId":"3feaf2",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Gardner syndrome"
]
},
" is a type of familial adenomatous polyposis with extraintestinal manifestations, including osteomas, duodenal ampullary tumors, thyroid cancers, and medulloblastomas."
]
},
{
"type":"p",
"hlId":"e93c95",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Lynch syndrome"
]
},
" is diagnosed if a patient has an identified germline mutation in one or more mismatch repair genes. ",
{
"type":"alert",
"children":[
"Lynch syndrome is an autosomal dominant disorder, and patients and family members should be offered genetic counseling and intense cancer surveillance. Lynch syndrome is also associated with an increased risk for extracolonic tumors, most commonly endometrial."
]
}
]
},
{
"type":"inline-wrap",
"wrapId":"1",
"contentIds":[
"mk19_bb_on_s4_inline_t1"
],
"forceOpen":true
},
{
"type":"heading",
"class":"tricked",
"children":[
"Don't Be Tricked"
]
},
{
"type":"list",
"class":"tricked",
"children":[
" ",
{
"type":"list-item",
"hlId":"64d2d7",
"children":[
"A single positive ",
{
"type":"abbreviation",
"title":"fecal occult blood testing",
"children":[
"FOBT"
]
},
" finding constitutes a positive screening test and requires prompt follow-up colonoscopy."
]
},
" "
]
}
]
},
{
"type":"section",
"id":"mk19_bb_on_s4_2",
"title":{
"__html":"Diagnosis"
},
"titleNode":{
"type":"section-title",
"hlId":"523223",
"children":[
"Diagnosis"
]
},
"children":[
{
"type":"p",
"hlId":"3e17ec",
"children":[
"Colonoscopy is the diagnostic procedure of choice."
]
}
]
},
{
"type":"section",
"id":"mk19_bb_on_s4_3",
"title":{
"__html":"Testing"
},
"titleNode":{
"type":"section-title",
"hlId":"fa6a5a",
"children":[
"Testing"
]
},
"children":[
{
"type":"p",
"hlId":"5989d1",
"children":[
"All cancers should undergo molecular testing to determine whether it has evidence of defective mismatch repair (dMMR) gene deficiency manifesting as DNA microsatellite instability. Patients whose tumors test positive should be screened for Lynch syndrome."
]
},
{
"type":"p",
"hlId":"3fdcea",
"children":[
"Staging also consists of contrast-enhanced CT of the abdomen, chest, and pelvis and a serum ",
{
"type":"abbreviation",
"title":"carcinoembryonic antigen",
"children":[
"CEA"
]
},
" level. Rectal cancers also require a rectal MRI."
]
},
{
"type":"heading",
"class":"tricked",
"children":[
"Don't Be Tricked"
]
},
{
"type":"list",
"class":"tricked",
"children":[
" ",
{
"type":"list-item",
"hlId":"fd4668",
"children":[
"Do not obtain a serum CEA level to screen for or diagnose colon cancer."
]
},
" ",
{
"type":"list-item",
"hlId":"35b027",
"children":[
"Do not obtain a ",
{
"type":"abbreviation",
"title":"positron emission tomography",
"children":[
"PET"
]
},
" scan for initial staging of colorectal cancer."
]
},
" "
]
}
]
},
{
"type":"section",
"id":"mk19_bb_on_s4_4",
"title":{
"__html":"Treatment"
},
"titleNode":{
"type":"section-title",
"hlId":"4c4ac0",
"children":[
"Treatment"
]
},
"children":[
{
"type":"p",
"hlId":"6ebe4a",
"children":[
"General rules for colon cancer therapy:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"227be8",
"children":[
"confined to colon (stage I) or local invasion (stage II) → resection for cure"
]
},
" ",
{
"type":"list-item",
"hlId":"9e3c0e",
"children":[
"metastatic to regional lymph nodes (stage III) → resection and adjuvant chemotherapy"
]
},
" ",
{
"type":"list-item",
"hlId":"30f1dc",
"children":[
"distant metastases (stage IV) → molecular analysis for K-",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"ras"
]
},
", N-",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"ras"
]
},
", and ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"BRAF"
]
},
" gene mutation status and ",
{
"type":"abbreviation",
"title":"defective mismatch repair",
"children":[
"dMMR"
]
},
" determination"
]
},
" "
]
},
{
"type":"p",
"hlId":"ff7ef2",
"children":[
" ",
{
"type":"alert",
"children":[
"Patients with an oligometastatic lesion to a single organ may be cured with surgical removal of the primary tumor and the metastasis."
]
},
" "
]
},
{
"type":"p",
"hlId":"6fc9f2",
"children":[
"5-FU–based adjuvant chemotherapy improves survival for patients with stage III colon cancer."
]
},
{
"type":"p",
"hlId":"d481f4",
"children":[
"5-FU–based adjuvant chemotherapy is efficacious for metastatic colon cancer. The addition of bevacizumab, a monoclonal antibody against ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"vascular endothelial growth factor",
"children":[
"VEGF"
]
},
","
]
},
" increases the efficacy of first- and second-line chemotherapy. The anti-",
{
"type":"abbreviation",
"title":"epidermal growth factor receptor",
"children":[
"EGFR"
]
},
" monoclonal antibody cetuximab or panitumumab may also be a useful addition to chemotherapy, but these agents are inactive in patients with K-",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"ras,"
]
},
" N-",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"ras,"
]
},
" or ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"BRAF"
]
},
" mutations."
]
},
{
"type":"p",
"hlId":"0ce3d3",
"children":[
"General rules for rectal cancer therapy:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"8515e3",
"children":[
"Rectal cancers that do not penetrate the full thickness of the bowel and do not involve regional lymph nodes are resected for cure."
]
},
" ",
{
"type":"list-item",
"hlId":"3d1939",
"children":[
"Full-thickness tumors and/or those with involved lymph nodes are treated with radiation, chemotherapy, and surgery."
]
},
" "
]
}
]
},
{
"type":"section",
"id":"mk19_bb_on_s4_5",
"title":{
"__html":"Follow-up"
},
"titleNode":{
"type":"section-title",
"hlId":"b9c20d",
"children":[
"Follow-up"
]
},
"children":[
{
"type":"p",
"hlId":"4ff0fa",
"children":[
"Recommended follow-up includes:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"d69dc4",
"children":[
"CEA measurement every 6 months for 5 years"
]
},
" ",
{
"type":"list-item",
"hlId":"edd72a",
"children":[
"colonoscopy 1 year later, 3 years later, and then every 5 years"
]
},
" ",
{
"type":"list-item",
"hlId":"4b86de",
"children":[
"CT of the abdomen, chest, and pelvis annually for 5 years"
]
},
" "
]
},
{
"type":"heading",
"class":"tricked",
"children":[
"Don't Be Tricked"
]
},
{
"type":"list",
"class":"tricked",
"children":[
" ",
{
"type":"list-item",
"hlId":"226dc6",
"children":[
"Do not use PET scans to follow patients for recurrent colorectal cancer."
]
},
" ",
{
"type":"list-item",
"hlId":"effa2c",
"children":[
"Anti-VEGF and anti-EGFR monoclonal antibodies should not be used together."
]
},
" ",
{
"type":"list-item",
"hlId":"c073a9",
"children":[
"Do not institute therapy for metastatic disease based on CEA elevation alone."
]
},
" "
]
}
]
},
{
"type":"section",
"id":"mk19_bb_on_s4_6",
"title":{
"__html":"Test Yourself"
},
"titleNode":{
"type":"section-title",
"hlId":"7866cc",
"children":[
"Test Yourself"
]
},
"children":[
{
"type":"p",
"hlId":"02cdac",
"class":"test",
"children":[
"A 71-year-old man is evaluated for stage II colon cancer that was resected 3 years ago. A surveillance CT scan shows three small metastatic lesions in the left lobe of the liver. No other abnormal findings are noted."
]
},
{
"type":"p",
"hlId":"d47b28",
"class":"test_answer",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Answer:"
]
},
" ",
"For management, select resection of all lesions."
]
}
]
}
]
},
"tablesContent":{
"mk19_bb_on_s4_inline_t1":{
"id":"mk19_bb_on_s4_inline_t1",
"number":1,
"bookId":"on",
"title":{
"__html":"Study Table: Screening for Colorectal Cancer in Individuals at Elevated Risk"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"3cd62e",
"children":[
"Study Table: Screening for Colorectal Cancer in Individuals at Elevated Risk"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2eebef",
"class":"col hd l",
"children":[
"Risk Category"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2e739b",
"class":"col hd l",
"children":[
"Criteria"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e4fd04",
"class":"col hd l",
"children":[
"Screening Recommendations (Age; Modality; Interval)"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e72433",
"class":"cell txt l",
"children":[
"Increased"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2bcd3e",
"class":"cell txt l",
"children":[
"Family history of CRC:"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d9d971",
"class":"cell txt li",
"children":[
"CRC diagnosed in FDR age <60 years or ≥2 FDRs at any age"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"80ef3f",
"class":"cell txt l",
"children":[
"Begin at age 40 years or 10 years earlier than age of youngest FDR at diagnosis, whichever comes first; colonoscopy; repeat every 5 years",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"95d2a3",
"class":"cell txt li",
"children":[
"CRC diagnosed in FDR age ≥60 years"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"60c487",
"class":"cell txt l",
"children":[
"Begin at age 40 years; any modality; repeat every 10 years",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a26db3",
"class":"cell txt li",
"children":[
"Personal history of CRC"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"98571d",
"class":"cell txt l",
"children":[
"Perform at time of diagnosis; colonoscopy; repeat at 1 year, 3 years, and, if normal, every 5 years thereafter until risks outweigh benefit of continued screening"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"840581",
"class":"cell txt li",
"children":[
"Adult patients with cystic fibrosis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e63299",
"class":"cell txt l",
"children":[
"Cystic Fibrosis Foundation recommends beginning CRC screening at age 40 years in individuals with cystic fibrosis, with continued rescreening every 5 years"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"655d20",
"class":"cell txt l",
"children":[
"High"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b130cd",
"class":"cell txt l",
"children":[
"Familial adenomatous polyposis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4a8843",
"class":"cell txt l",
"children":[
"Begin at age 10-12 years; flexible sigmoidoscopy or colonoscopy; repeat every 1-2 years until colectomy"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"60067b",
"class":"cell txt l",
"children":[
"Lynch syndrome"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5b5163",
"class":"cell txt l",
"children":[
"Begin at age 20-25 years or 10 years earlier than youngest cancer in family; colonoscopy; repeat every 1-2 years"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9d9dc4",
"class":"cell txt l",
"children":[
"Inflammatory bowel disease (Crohn disease or ulcerative colitis)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a689dc",
"class":"cell txt l",
"children":[
"Begin after 8 years of chronic colitis; colonoscopy with biopsies; repeat every 1-2 years"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"CRC = colorectal cancer; FDR = first-degree relative (parent, sibling, or child)."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"If baseline examination is normal."
],
[
"Data from Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2017;153:307-323. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/28600072",
"target":"_blank"
},
"children":[
"PMID: 28600072"
]
},
" doi:10.1053/j.gastro.2017.05.013; Syngal S, Brand RE, Church JM, et al.; American College of Gastroenterology. ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol. 2015 Feb;110(2):223-62; quiz 263. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/25645574",
"target":"_blank"
},
"children":[
"PMID: 25645574"
]
},
"; Rubin DT, Ananthakrishnan AN, Siegel CA, et al. ACG clinical guideline: ulcerative colitis in adults. Am J Gastroenterol. 2019;114:384-413. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/30840605",
"target":"_blank"
},
"children":[
"PMID: 30840605"
]
},
" doi:10.14309/ajg.0000000000000152"
]
]
}
}
}